Since 2012, our journey has been driven by a clear vision and with the researches, Quantum Medis began with a single vision — to transform the natural potential of cannabinoids into reliable, science-driven therapeutic solutions. At a time when the global CBD market was still in its infancy, our research team focused on one key challenge: how to deliver cannabinoids in a form that ensures both purity and bioavailability, while maintaining full compliance with pharmaceutical standards.

Through years of intensive study into CBD and THC interactions, formulation chemistry, and mucosal absorption dynamics, we developed a truly innovative solution — a natural, orodispersible CBD tablet that dissolves directly in the mouth. This breakthrough allows for rapid absorption through the oral mucosa, bypassing the digestive system to achieve faster onset, improved consistency, and superior bioavailability compared to traditional oils or capsules.

Our work led to the successful granting of patents in the European Union and Switzerland, recognizing the originality and technological value of our invention. To safeguard this innovation, Quantum Medis deliberately delayed publication of our data until full patent protection had been secured, ensuring the integrity of our intellectual property before public disclosure.

Today, our patented CBD orodispersible tablet represents more than a decade of research, refinement, and collaboration with leading European laboratories. It embodies our core philosophy — that the future of wellness lies at the intersection of nature and advanced biotechnology.